ACMT Recommends Against Use of Post-Chelator Challenge Urinary Metal Testing

Overview

Journal J Med Toxicol

Publisher Springer

Specialty Toxicology

Date 2017 Jul 21

PMID 28726084

Citations 1

Affiliations

Soon will be listed here.

Citing Articles

Trends in Shortages of Lead Chelators From 2001 to 2022.

Whitledge J, Soto P, Glowacki K, Calello D, Fox E, Mazer-Amirshahi M J Pediatr Pharmacol Ther. 2024; 29(3):306-315.

PMID: 38863853 PMC: 11163907. DOI: 10.5863/1551-6776-29.3.306.

References

Bradberry S, Wilkinson J, Ferner R . Systemic toxicity related to metal hip prostheses. Clin Toxicol (Phila). 2014; 52(8):837-47. DOI: 10.3109/15563650.2014.944977. View

Sherrard D, Walker J, Boykin J . Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease. Am J Kidney Dis. 1988; 12(2):126-30. DOI: 10.1016/s0272-6386(88)80007-6. View

Vamnes J, Eide R, Isrenn R, Hol P, Gjerdet N . Diagnostic value of a chelating agent in patients with symptoms allegedly caused by amalgam fillings. J Dent Res. 2000; 79(3):868-74. DOI: 10.1177/00220345000790031401. View

Smith D, Calacsan C, Woolard D, Luck M, Cremin J, Laughlin N . Succimer and the urinary excretion of essential elements in a primate model of childhood lead exposure. Toxicol Sci. 2000; 54(2):473-80. DOI: 10.1093/toxsci/54.2.473. View

Rooney J . The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology. 2007; 234(3):145-56. DOI: 10.1016/j.tox.2007.02.016. View

Kalia K, Flora S . Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J Occup Health. 2005; 47(1):1-21. DOI: 10.1539/joh.47.1. View

Kales S, Goldman R . Mercury exposure: current concepts, controversies, and a clinic's experience. J Occup Environ Med. 2002; 44(2):143-54. DOI: 10.1097/00043764-200202000-00009. View

Ruha A . Recommendations for provoked challenge urine testing. J Med Toxicol. 2013; 9(4):318-25. PMC: 3846974. DOI: 10.1007/s13181-013-0350-7. View

Basinger M, Jones M, Holscher M, Vaughn W . Antagonists for acute oral cadmium chloride intoxication. J Toxicol Environ Health. 1988; 23(1):77-89. DOI: 10.1080/15287398809531095. View

10.

Dietrich K, Ware J, Salganik M, Radcliffe J, Rogan W, Rhoads G . Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics. 2004; 114(1):19-26. DOI: 10.1542/peds.114.1.19. View

11.

Fayez I, Paiva M, Thompson M, Verjee Z, Koren G . Toxicokinetics of mercury elimination by succimer in twin toddlers. Paediatr Drugs. 2005; 7(6):397-400. DOI: 10.2165/00148581-200507060-00008. View

12.

Frumkin H, MANNING C, Williams P, Sanders A, Taylor B, Pierce M . Diagnostic chelation challenge with DMSA: a biomarker of long-term mercury exposure?. Environ Health Perspect. 2001; 109(2):167-71. PMC: 1240638. DOI: 10.1289/ehp.01109167. View

13.

Powell J, Burden T, Greenfield S, Taylor P, Thompson R . Urinary excretion of essential metals following intravenous calcium disodium edetate: an estimate of free zinc and zinc status in man. J Inorg Biochem. 1999; 75(3):159-65. DOI: 10.1016/s0162-0134(99)00054-9. View

14.

CHISOLM Jr J, Thomas D . Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children. J Pharmacol Exp Ther. 1985; 235(3):665-9. View

15.

Brown M, Willis T, Omalu B, Leiker R . Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005. Pediatrics. 2006; 118(2):e534-6. DOI: 10.1542/peds.2006-0858. View

16.

Lillevang S, Pedersen F . Exacerbation of aluminium encephalopathy after treatment with desferrioxamine. Nephrol Dial Transplant. 1989; 4(7):676. View

17.

Brodkin E, Copes R, Mattman A, Kennedy J, Kling R, Yassi A . Lead and mercury exposures: interpretation and action. CMAJ. 2007; 176(1):59-63. PMC: 1764574. DOI: 10.1503/cmaj.060790. View

18.

Risher J, Amler S . Mercury exposure: evaluation and intervention the inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning. Neurotoxicology. 2005; 26(4):691-9. DOI: 10.1016/j.neuro.2005.05.004. View

19.

Stangle D, Smith D, Beaudin S, Strawderman M, Levitsky D, Strupp B . Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure. Environ Health Perspect. 2007; 115(2):201-9. PMC: 1831518. DOI: 10.1289/ehp.9263. View

20.

McCauley J, Sorkin M . Exacerbation of aluminium encephalopathy after treatment with desferrioxamine. Nephrol Dial Transplant. 1989; 4(2):110-4. View